|
I think they are saying on average triple + bc is seen in younger women. 5 years younger than average age of other types bc.
Ding, ding, ding.... I am a winner. Triple + at 38 years young.
"Our findings suggest a strong age-related selective growth advantage for breast tumour cells belonging to the ER(+)PR(+)HER-2(+) subgroup."
Now what exactly is the growth advantage? I have always wondered if oral contraceptive use combined with delayed or no childbirth is an inconvenient combo.
__________________
Are we there yet?
Dx 10/05 IDC, multi-focal, triple +, 5 nodes+
MRM, 4 DD A/C, 12 weekly taxol + herceptin
rads concurrent with taxol/herceptin
finished herceptin 01/08
ooph, Arimidex, bilateral DIEP reconstruction
NED
Univ. of WA, Seattle vaccine trial '07
|